Casdin Private Growth Equity Fund II GP, LLC
SEC CIK 1919480 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | Dir | 11.50M | $3.27M | — | 2 | 2023-05-17 | 2024-03-04 |
Most active insiders at LAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners GP, LLC | Dir, 10% | $11.41M | — |
| 2 | Casdin Eli | Dir, 10% | $1.37M | — |
| 3 | Casdin Partners Master Fund, L.P. | Dir, 10% | $1.12M | — |
| 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | $503.0K | — |
| 5 | Kim Hanjoon Alex | CFO | — | — |
| 6 | Mackay Sean | SVP, Chief Business Off | — | — |
| 7 | Cox Troy | Dir | — | — |
| 8 | Carey Thomas D. | Dir | — | — |
| 9 | Egholm Michael | Pres, CEO, Dir | — | — |
| 10 | Witney Frank | Dir | — | — |
Casdin Private Growth Equity Fund II GP, LLC made no open-market trades at LAB in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-06 | 2024-03-04+ | LAB | STANDARD BIOTOOLS INC. | Casdin Private Growth Equity Fund II GP, LLC | Dir | P - Purchase | $2.57 | +251.4K | 11.50M | +2% | +$646.2K |
| MI | 2023-05-19 | 2023-05-17+ | LAB | STANDARD BIOTOOLS INC. | Casdin Private Growth Equity Fund II GP, LLC | Dir | P - Purchase | $2.19 | +1.20M | 1.20M | New | +$2.63M |
Purchase Sale Sale after option exercise All abbreviations